Synthetic cannabinoid products being sold in convenience stores and gas stations across the US are contaminated with an ingredient commonly found in rat poison, the US Food and Drug Administration (FDA) says.
These products, often sold under such names as K2 and Spice, are marketed as alternatives to marijuana. According to a statement issued by the FDA they are illegally marketed for their psychoactive effects.
Some also contain brodifacoum, “a very long-acting anticoagulant commonly used in rat poison”, which is thought by drug producers to extend the high. Since there is no way for consumers to verify which of these products have been contaminated with brodifacoum, the agency adds, they should avoid synthetics altogether.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Do the Novel Food regulations in Europe affect your business?
CBD as a Novel Food: the future for edibles in Europe
This new CBD-Intel report examines key aspects and drivers of the edibles market itself before looking in detail at the Novel Food regulations, both at EU level and in non-EU markets: notably the UK, as well as Switzerland and Norway.
Questions it considers and answers include whether CBD really is novel, whether approvals are likely to be generic or applicant-specific, how the Novel Food Catalogue and RASFF operate, and the costs of Novel Food applications.
This report also includes a 1-hour consultation call with CBD-Intel’s analyst team.